←Back to Expert Scholars
Translational Medicine / 转化医学Bispecific Antibodies, Lymphoma
Julio Chavez
MD, MS
🏢Moffitt Cancer Center🌐USA
Director, Lymphoma Clinical Trials
40
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Julio Chavez directs lymphoma clinical trials at Moffitt and has led studies of bispecific antibodies and CAR-T in relapsed DLBCL. He has contributed to epcoritamab and glofitamab development. His work expands therapeutic options for relapsed lymphoma.
Share:
🧪Research Fields 研究领域
bispecific antibodies
DLBCL
epcoritamab
CAR-T lymphoma
novel lymphoma agents
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Julio Chavez 的研究动态
Follow Julio Chavez's research updates
留下邮箱，当我们发布与 Julio Chavez（Moffitt Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment